Valuation: IRADIMED CORPORATION

Market Cap 1.07B 969M 895M 807M 1.52B 99.71B 1.58B 10.78B 4.27B 53.8B 4B 3.92B 170B P/E 2026 *
43.6x
P/E 2027 * 37.4x
Enterprise Value 1.07B 969M 895M 807M 1.52B 99.71B 1.58B 10.78B 4.27B 53.8B 4B 3.92B 170B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 10.4x
Free-Float
64.76%
Yield 2026 *
-
Yield 2027 * -
1 day-1.64%
1 week-3.77%
Current month+8.83%
1 month-5.46%
3 months-5.19%
6 months-3.46%
Current year-14.22%
1 week 83.21
Extreme 83.21
87.46
1 month 76.35
Extreme 76.35
89.48
Current year 76.35
Extreme 76.35
107.9
1 year 76.35
Extreme 76.35
107.9
3 years 40.05
Extreme 40.05
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
9/23/26 A Exercice

Director

1,396 0.0109%
9/3/26 A Sell

Director

-1,419 0.0111%
6/4/26 A Sell

Director

-3,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-3.77%-2.31%+97.66% 1.07B
-0.66%-4.37%+21.09%+47.25% 254B
-1.80%-4.38%+2.42%+8.66% 159B
-1.65%-4.34%-21.25%+41.03% 149B
-1.51%-3.74%-57.71%-20.81% 62.37B
-1.57%+1.37%+24.42%+57.59% 60.62B
-1.59%+0.84%+3.64%-13.47% 53.05B
-0.40%-3.18%+19.17%+52.21% 48.55B
-3.63%-5.61%+4.12%+63.37% 46.7B
-0.80%-5.41%+19.00%+71.75% 44.21B
Average -1.52%-2.24%+1.26%+40.52% 88B
Weighted average by Cap. -1.36%-2.99%+2.97%+33.86%

Financials

2026 *2027 *
Net sales 92.2M 83.7M 77.32M 69.75M 132M 8.61B 137M 932M 368M 4.65B 346M 339M 14.69B 102M 92.9M 85.82M 77.42M 146M 9.56B 152M 1.03B 409M 5.16B 384M 376M 16.3B
Net income 24.57M 22.3M 20.6M 18.59M 35.09M 2.3B 36.43M 248M 98.19M 1.24B 92.17M 90.23M 3.91B 28.8M 26.14M 24.15M 21.79M 41.13M 2.69B 42.71M 291M 115M 1.45B 108M 106M 4.59B
Net Debt - -
Projected Income Statement - Annual - IRADIMED CORPORATION
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
17/11/26 $83.45 -1.64% 85,461
16/11/26 $84.84 -0.60% 82,775
13/11/26 $85.35 +0.14% 115,214
12/11/26 $85.23 -1.56% 71,654
11/11/26 $86.58 -0.16% 79,774
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - IRADIMED CORPORATION
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
83.45USD
Average target price
118.00USD
Spread / Average Target
+41.40%
  1. Stock Market
  2. Stocks
  3. IRMD Stock